Gemphire Therapeutics Inc. (GEMP): Cormorant Asset Management Reports New Stake

Page 6 of 8 – SEC Filing
Item 1.
(a)
Name of Issuer
Gemphire Therapeutics Inc.
(b)
Address of Issuer’s Principal Executive Offices
43334 Seven Mile Road, Suite 1000
Northville, MI 48167
Item 2.
(a)
Name of Person Filing
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LLC
Bihua Chen
 
(b)
Address of Principal Business Office or, if none, Residence
200 Clarendon Street, 52nd Floor
Boston, MA 02116
(c)
Citizenship
Cormorant Global Healthcare Master Fund, LP – Cayman Islands
Cormorant Global Healthcare GP, LLC – Delaware
Cormorant Asset Management, LLC – Delaware
Bihua Chen – United States
(d)
Title of Class of Securities
Common Stock
(e)
CUSIP Number
36870A108

Follow Neurobo Pharmaceuticals Inc. (NASDAQ:NRBO)